Gilead Sciences, Inc. v. Lupin Ltd. et al
| Gilead Sciences, Inc. |
| Lupin Ltd., Laurus Labs Limited and Cipla Limited |
| 1:2022cv00615 |
| May 9, 2022 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 13, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Lupin Ltd. waiver sent on 5/10/2022, answer due 7/11/2022. (Tigan, Jeremy) |
SO ORDERED re #9 MOTION for Pro Hac Vice Appearance of Attorney J. Scott McBride, Matthew R. Ford, Rebecca T. Horwitz, and Taylor J. Kelson filed by Gilead Sciences, Inc. ORDERED by Judge Maryellen Noreika on 5/12/2022. (dlw)
|
| Filing 11 WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Cipla Limited waiver sent on 5/11/2022, answer due 7/11/2022. (Tigan, Jeremy) |
| Filing 10 WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Laurus Labs Limited waiver sent on 5/10/2022, answer due 7/11/2022. (Tigan, Jeremy) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney J. Scott McBride, Matthew R. Ford, Rebecca T. Horwitz, and Taylor J. Kelson - filed by Gilead Sciences, Inc.. (Tigan, Jeremy) |
| Filing 8 Summons Issued as to Lupin Ltd. on 5/9/2022. (srs) |
| Filing 7 Summons Issued as to Cipla Limited on 5/9/2022. (srs) |
| Filing 6 Summons Issued as to Laurus Labs Limited on 5/9/2022. (srs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (srs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,708,342 B2 ;10,385,067 B2 ;10,548,846 B2. (srs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Lupin Ltd: On or about March 28, 2022. Laurus Labs Limited: On or about March 31, 2022. Cipla Limited: On or about April 1, 2022. Date of Expiration of Patent: U.S. Patent No. 9,708,342: June 19, 2035. U.S. Patent No. 10,385,067: June 19, 2035. U.S. Patent No. 10,548,846: November 8, 2036.Thirty Month Stay Deadline: 8/7/2025. (srs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Filing 1 COMPLAINT FOR PATENT INFRINGMENT filed against Cipla Limited, Laurus Labs Limited, and Lupin Ltd. ( Filing fee $ 402, receipt number ADEDC-3869547.) - filed by Gilead Sciences, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet)(srs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
